Market Resilience: Terns Pharmaceuticals Inc (TERN) Finishes Weak at 2.10, Down -9.87

Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.

Terns Pharmaceuticals Inc (NASDAQ: TERN) closed the day trading at $2.10 down -9.87% from the previous closing price of $2.33. In other words, the price has decreased by -$9.87 from its previous closing price. On the day, 1.44 million shares were traded. TERN stock price reached its highest trading level at $2.29 during the session, while it also had its lowest trading level at $2.08.

Ratios:

For a better understanding of TERN, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 23.14 and its Current Ratio is at 23.14. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

On October 31, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $82.

On June 22, 2023, Mizuho started tracking the stock assigning a Buy rating and target price of $16.Mizuho initiated its Buy rating on June 22, 2023, with a $16 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 01 ’25 when Kuriakose Emil sold 952 shares for $2.49 per share. The transaction valued at 2,366 led to the insider holds 53,317 shares of the business.

Jung Melita Sun bought 2,250 shares of TERN for $11,498 on Nov 30 ’24. The Chief Business Officer now owns 2,250 shares after completing the transaction at $5.11 per share. On Nov 30 ’24, another insider, Burroughs Amy L., who serves as the Chief Executive Officer of the company, bought 510 shares for $5.11 each. As a result, the insider paid 2,606 and bolstered with 19,609 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TERN now has a Market Capitalization of 183324944 and an Enterprise Value of -173491984.

Stock Price History:

The Beta on a monthly basis for TERN is -0.07, which has changed by -0.6188748 over the last 52 weeks, in comparison to a change of -0.024663687 over the same period for the S&P500. Over the past 52 weeks, TERN has reached a high of $11.40, while it has fallen to a 52-week low of $2.32. The 50-Day Moving Average of the stock is -43.18%, while the 200-Day Moving Average is calculated to be -66.96%.

Shares Statistics:

Over the past 3-months, TERN traded about 1.41M shares per day on average, while over the past 10 days, TERN traded about 1256970 shares per day. A total of 87.13M shares are outstanding, with a floating share count of 65.30M. Insiders hold about 25.20% of the company’s shares, while institutions hold 78.65% stake in the company. Shares short for TERN as of 1741910400 were 5947873 with a Short Ratio of 4.22, compared to 1739491200 on 5915984. Therefore, it implies a Short% of Shares Outstanding of 5947873 and a Short% of Float of 7.470000000000001.

Dividends & Splits

Against a Trailing Annual Dividend Yield of 0.0

Most Popular